Chlorantraniliprole 13CD3; 3-bromo-N-{4-chloro-2-methyl-6-[(methylamino)carbonyl]phenyl}-1-(3-chloro-2-pyridinyl)-1H-pyrazole-5-carboxamide 13CD3;Coragen-13CD3; DKI 0001-13CD3; DPX-E 2Y45-13CD3; Dermacor X 100-13CD3; E 2Y45-13CD3; Prevathon-13CD3; Rynaxypyr-13CD3; 3-Bromo-N-[4-chloro-2-methyl-6-[(methylamino)carbonyl]phenyl]-1-(3-chloro-2-pyridinyl)-1H-pyrazole-5-carboxamide-13CD3; Acelepryn-13CD3; Altacor-13CD3; Altacor 35WG-13CD3; Altriset-13CD3; Calteryx-13CD3; 3-Bromo-N-[4-chloro-2-methyl-6-[(methylamino)carbonyl]phenyl]-1-(3-chloro-2-pyridinyl)-1H-pyrazole-5-carboxamide
Chloroantraniliprole 13CD3 is a fully characterized chemical compound used as a reference standard of API Chloroantraniliprole. The standard offered is compliant with regulatory guidelines. Chloroantraniliprole 13CD3 is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 500008-45-7 (Un labeled)
